Invention Grant
- Patent Title: Combinations of LSD1 inhibitors for use in the treatment of solid tumors
-
Application No.: US15458640Application Date: 2017-03-14
-
Publication No.: US10265279B2Publication Date: 2019-04-23
- Inventor: Mark D. Demario , Tamara Maes , William E. Pierceall , Fiona Mack , Serena Lunardi
- Applicant: ORYZON GENOMICS, S.A.
- Applicant Address: ES Madrid
- Assignee: Oryzon Genomics, S.A.
- Current Assignee: Oryzon Genomics, S.A.
- Current Assignee Address: ES Madrid
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/135
- IPC: A61K31/135 ; A61K31/55 ; A61K31/551 ; A61K31/4402 ; A61K31/47 ; A61K31/52 ; A61K31/404 ; A61K31/635 ; A61K31/167 ; A61K31/4545 ; A61K31/496 ; A61K31/5377 ; A61K31/4745 ; A61K31/12 ; A61K31/19 ; A61K31/282 ; A61K31/337 ; A61K31/4045 ; A61K31/475 ; A61K31/495 ; A61K31/519 ; A61K31/555 ; A61K31/704 ; A61K31/7068
Abstract:
The instant invention relates to therapeutic combinations of LSD1 inhibitors and one or more other active pharmaceutical ingredient(s) or pharmaceutically acceptable salts thereof. The combinations are particularly useful for treating neoplastic diseases, such as cancer, particularly small cell lung cancer (SCLC).
Public/Granted literature
- US20170281567A1 COMBINATIONS OF LSD1 INHIBITORS FOR USE IN THE TREATMENT OF SOLID TUMORS Public/Granted day:2017-10-05
Information query
